Sympathetic Nerve Activity and Strength Gains in Resistance Versus Concurrent Training (SKNA-CT)

June 25, 2026 updated by: Beijing Sport University

Sympathetic Activation and Strength Gains Rise Together Under Resistance Training But Uncouple Under Concurrent Training: An 8-Week Randomized Controlled Trial in Untrained Men

This study examines how the body's stress (sympathetic) nervous system responds to 8 weeks of either strength training alone or strength training combined with endurance (treadmill running) training in previously untrained young men. Skin sympathetic nerve activity, a noninvasive marker of sympathetic nervous system activity, is measured before and after training, along with muscle strength, jumping ability, and heart rate variability. The study investigates whether changes in sympathetic nervous system activity are associated with changes in strength and jumping ability, and whether this relationship differs between men who perform strength training alone versus those who combine strength and endurance training.

Study Overview

Detailed Description

This study examined how the body's stress (sympathetic) nervous system responds to 8 weeks of either strength training alone or strength training combined with endurance (treadmill running) training in previously untrained young men. Skin sympathetic nerve activity, a noninvasive marker of sympathetic nervous system activity, was measured before and after training, along with muscle strength, jumping ability, and heart rate variability. The study found that in men who did strength training only, those whose sympathetic nervous system activity increased the most also gained the most strength and jumping ability. This relationship was not seen, and in some cases reversed, in men who combined strength training with endurance training. The findings suggest that adding endurance exercise changes how the nervous system adapts to a strength training program, alongside the well-documented reduction in strength gains seen with combined training (the "interference effect").

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China, 100091
        • Beijing sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy young men
  • No hypertension or cardiovascular/vascular disease
  • No migraine or neurodegenerative disease
  • No smoking or alcohol use
  • No prior structured exercise training
  • No musculoskeletal injury
  • Willing to abstain from caffeine, alcohol, and strenuous exercise for 24 hours before testing

Exclusion Criteria:

  • Hypertension or cardiovascular/vascular disease
  • Migraine or neurodegenerative disease
  • Current smoking or alcohol use
  • Prior structured exercise training history
  • Musculoskeletal injury precluding resistance or endurance exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Strength-only training
Participants performed a supervised resistance training program three times weekly for 8 weeks: weighted calf raises (80% 1RM, 4x6), back squats (75% 1RM, 4x6), countermovement jumps (60-cm target height, 4x6), and weighted lunges (60% 1RM, 4x5), using a Smith machine.
Supervised resistance exercise comprising weighted calf raises, back squats, countermovement jumps, and weighted lunges, performed on a Smith machine three times weekly for 8 weeks.
Experimental: Concurrent training
Participants performed the identical resistance training program as the Strength-only arm, followed by 30-40 minutes of moderate-intensity treadmill running (46-64% VO2max) once heart rate had returned to 40% of maximum, three times weekly for 8 weeks (a strength-priority exercise sequence).
performed on a Smith machine three times weekly for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
skin sympathetic nerve activity (aSKNA)
Time Frame: Baseline and 8 weeks
Average rectified voltage of skin sympathetic nerve activity recorded noninvasively via the neuECG method.
Baseline and 8 weeks
Change in one-repetition maximum (1RM) back squat
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks
Change in countermovement jump (CMJ) height
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in CMJ peak velocity
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks
Change in CMJ peak power
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks
Change in SKNA burst duration
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks
Change in SKNA burst amplitude
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks
Change in SKNA burst total area
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks
Change in CMJ peak force
Time Frame: Baseline and 8 weeks
Baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2024

Primary Completion (Actual)

December 12, 2024

Study Completion (Actual)

December 13, 2024

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

June 25, 2026

First Posted (Actual)

July 2, 2026

Study Record Updates

Last Update Posted (Actual)

July 2, 2026

Last Update Submitted That Met QC Criteria

June 25, 2026

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underlie the results reported in this article will be made available upon reasonable request to the corresponding author.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sympathetic Nervous System

Clinical Trials on Strength-only training

3
Subscribe